The impact of different approaches to fl uid management during intraoperative volume resuscitation in patients undergoing major elective surgery is poorly defi ned. We compared volume effectiveness of crystalloid and colloid substitution aimed to maintain the cardiac index (CI) between 2.6 and 3.8 l/min/ m 2 as measured by transesophageal Doppler (TED). Methods: A total of 115 urological patients were enrolled in the prospective randomized trial and then randomized into 2 groups, one with volume therapy based on crystalloids (n = 57) and the other with colloids (n = 58). A TED probe was inserted and then hemodynamic optimization (therapy with Ringer's solution or hydroxyethyl starch 6 % 130/0.4 and administration of vasoactive drugs) was started according to TED variables to maintain the CI between 2.6 and 3.8 l/min/m 2 . Results: We observed high incidence of CI < 2.6 l/min/m 2 after induction of anesthesia (75 %) in both groups. There were no signifi cant differences in demographic characteristics, ASA classifi cation, length of surgery, estimated blood loss and the CI during surgery. To maintain the CI within the requested interval, signifi cantly different amounts of crystalloids were needed as compared to colloid (median: 5000 ml vs 1500 ml). In the CRY group, more patients were treated by vasodilatators (40.4 vs 20.7 %).
Abbreviations: Acc -peak aortic blood fl ow acceleration, ASA score -American Society of Anesthesiologists score, CI -cardiac index, CRY group -crystalloid group, COL group -colloid group, CVP -central venous pressure, FFP -fresh frozen plasma HRheart rate, IV -intravenous application, LVETi -left ventricular ejection time index, MAP -mean arterial pressure, RBC -red blood cells, TED -transesophageal dopplerometry, TSVRi -total systemic vascular resistance index.
The main goals of fl uid therapy are volume expansion and restoration and maintenance of adequate perfusion and oxygen delivery; this therapy should always be adjusted to individual hemodynamic goals. However, there are some clinical conditions in which volume therapy could be harmful, such as fl uid overload, followed by tissue edema formation and increased cardiac fi lling pressure. A common practice is co-administration of fl uids and vasoactive agents, which is supposed to reduce the above risk.
Crystalloid and colloid solutions have, according to their pharmacokinetics, different distribution between body compartments. Older studies, which included patients with trauma and hemorrhagic shock, described the need to use approximately three times the amount of crystalloids compared with colloids for restoration of effective tissue perfusion during emergency fl uid resuscitation (1, 2, 3). These fi ndings correspond with the traditional view of the fl uid shift between the intravascular and interstitial spaces (4). However, some recently published studies comparing volume effectiveness of these solutions questioned some of the conclusions. According to the SAFE study, 1.16 to 1.3 times more saline solution than 4 % albumin is needed to reach the same values of mean arterial pressure (MAP) in the fi rst four days of hospitalization (5). Another study (major cardiac and vascular surgery) performed in the early postoperative period comparing volume effectiveness of crystalloids and different colloids observed that the adequate volume ratio would be 1.2 : 1 (6). Infl uence of the used vasoactive agents on global perfusion was not evaluated in these studies. Based on these results, some authors recommended reviewing the traditional opinions related to the ratio of crystalloid and colloid solutions used during volume resuscitation.
The aim of this study was to compare volume effectiveness of colloids and crystalloids during major elective urological surgery using fl ow-related values derived by transesophageal Doppler (TED) monitoring. The therapeutic algorithm included the use of titrated doses of vasoactive agents in case there were some abnormalities in myocardial contractility and afterload values. Another goal was to fi nd out if the type of solution used has infl uence on the frequency of postoperative complications and prognosis of the patient.
Patients and methods
A total of 115 consecutive patients undergoing elective major urological surgery have been enrolled in a prospective randomized clinical study (Fig. 1) . The study was approved by the Institutional Research Ethics Committee and was carried out in operating theatres and an intensive care unit (ICU) of a tertiary hospital. Statement of the Ethics Committee confi rms that all the activities and the structure of members of the Ethics Committee is in compliance with the international rules of conducting clinical trials. The exclusion criteria were age under 21 years, emergency surgery, pregnancy, severe cardiac or respiratory failure and expected duration of surgery less than 90 minutes. Informed consent was obtained from all patients enrolled in the study.
The patients were randomized and allocated according to the sequentially numbered, sealed opaque envelope technique. There were no restrictions or stratifi cation in the randomization process. The research nurse assigning the patients to either the crystalloid (CRY, n = 57) or colloid (COL, n = 58) groups opened the allocation envelope immediately before induction of general anesthesia. After the induction, each patient obtained a TED probe (Hemosonic TM 100 ® , Arrow International, Inc., Reading, PA, USA). Then hemodynamic optimization (fl uid therapy with Ringer's solution or hydroxyethyl starch 6 % 130/0.4 and administration of vasoactive drugs) was started according to TED variables to maintain the cardiac index (CI) between 2.6 and 3.8 l/min/m 2 . In each patient from any of the groups, the probe was inserted through the mouth to the distal third of the esophagus. According to the predefi ned therapeutic management algorithm (Fig. 2) , fl uids, inotropic support with dobutamine (Dobutamin Lachema 250, Pliva-Lachema a.s., Brno, Czech Republic), and vasoactive support with noradrenaline (Noradrenalin Leciva, Zentiva, Czech Republic) or isosorbide dinitrate (Isoket roztok 0.1 %, Schwarz Pharma AG, Monheim, Germany) were used. To compare the volume effi cacy of maintaining the CI in the normal range with crystalloids or colloids, Ringer's solution (Ringer's injection, Fresenius Kabi, Verona, Italy) for volume resuscitation was used in the CRY group and hydroxyethyl starch (HES, Voluven ® , Fresenius Kabi AG, Bad Homburg, Germany) in the COL group. Concentration of hemoglobin lower than 90 g/l was an indication to start blood substitution. The supplementation of immeasurable fl uid losses in the COL group was performed with Ringer's solution 0.05 ml/kg/min. None of the patients was excluded after randomization.
All patients had their bowels prepared by enema and/or using phosphate solution in the evening before surgery. This therapy was extended by administration of bisacodyl (Fenolax ® , ICN Polfa, Rzeszow, Poland) and colonoscopy preparation diet in case of planned radical cystectomy. The patients were encouraged to drink water until midnight. Intravenous fl uids, usually used overnight to minimize dehydration before surgery, were not administered due to local urological recommendations.
General anesthesia was induced with propofol and maintained with a balanced technique incorporating mixed nitrous oxide and oxygen, isofl urane with cisatracurium providing muscle relaxation. Sufentanil was used for analgesia at the anesthetist's discretion. The patients were intubated and ventilated to normocapnia throughout the operation. Standard monitoring included ECG, pulse oxymetry, capnography, and measurement of invasive arterial blood pressure. Prior to the operation, central venous catheter was introduced in 50 patients (88 %) in the CRY group and 49 patients (84 %) in the COL group. Intraoperative epidural analgesia was never used.
All patients enrolled in the study were admitted to a surgical ICU after the procedure and followed until discharge from the hospital. The following parameters were recorded: length of ICU stay, length of hospital stay, rate of postoperative complications and in-hospital mortality. The evaluation of postoperative complications was similar to the method used by Bennett-Guerrero and colleagues (7).
Pri mary endpoint was defi ned as the comparison of volume replacement effi ciency of crystalloids and colloids during major urological surgery. This effi ciency was measured by fl ow-related perfusion parameters derived by transesophageal Doppler (TED) monitoring. Secondary endpoints included postoperative complications, ICU length of stay, length of stay in hospital and mortality related to the type of used fl uids.
For sample size estimation, 750 ml difference in the amount of administered fl uids (with a 5 % signifi cance level and 80 % power, SD 1250 ml) was considered clinically important. A sample size of 45 patients in both groups (i.e. 90 patients) was necessary. For the particular sample size, variability and difference in the mean volume of intraoperatively administered fl uids between the colloid and crystalloid groups, the power of the test was found to be almost 100 %. This power of the test is suffi cient with respect to differences found by the study.
Data on patient characteristics, complications, and Doppler measurement were extracted from the (electronic) patient records. To ensure a proper execution of the trial and to monitor the progress, outcome, and patient safety during the trial, its progress and any occurring adverse events were discussed regularly with an expert team that was not involved in the randomization procedure or postoperative treatment of the patients.
Statistical analysis was carried out by an independent statistical institution. The Mann-Whitney U test was applied to compare continuous variables and the chi-square or Fisher's exact tests were used for categorical variables. The Wilcoxon matched pairs test was adopted for the comparison of paired measurements of patients. A p value of less than 0.05 was considered statistically signifi cant.
Results
During the inclusion period 115 patients were potentially suitable for the study. After screening, all patients match all inclusion criteria. The fl ow chart of the number of patients at inclusion, during follow-up and available for analysis is shown in Figure 3 . We therefore analyzed the results of all 115 patients who were included and had entered the protocol. Demographic data of all patients enrolled in the study are presented in Table 1 . Statistical analysis did not show any differences in age (median: 61 years in the CRY group vs 63.5 years in the COL group), gender (males: 71.9 % vs 72.4 %), body surface area (median: 2.0 vs 2.0), and estimated risk of anesthesia according to the ASA classifi cation (median: 2.0 vs 2.0). Most of the patients underwent surgery for a tumor (78.9 % in the CRY group vs 79.3% in the COL group). The most frequent surgery was radical prostatectomy (42.1 % vs 39.7 %), followed by nephrectomy (35.1 % vs 41.4 %) and cystectomy (22.8 % vs 19 %). Data concerning surgery are presented also in Table 1 . All surgeries lasted at least 90 minutes (median: 155 minutes in the CRY group vs 150 minutes in the COL group). To maintain the CI within the requested interval, signifi cantly different amounts of crystalloids compared to colloids were needed (median: 5000 ml vs 1500 ml, p = 0.001, respectively).Total amount of fl uids (except for red blood cells and fresh frozen plasma) was 5000 ml in the CRY group vs 2200 ml in the COL group. The number of intraoperatively administered blood units was also higher in CRY group than in the COL group (red blood cells: median 0.9 vs 0.3 p = 0.018; fresh frozen plasma: median 1.0 vs 0.3, p = 0.006, respectively). However, the differences in administered blood units and fresh frozen plasma within the day of surgery were not signifi cant. Signifi cant differences were found in the use of vasoactive agents during the surgery. In the CRY group, more vasodilators (40.4 % vs 20.7%) were used. The differences in amounts of administered inotropic and vasoactive drugs were not statistically signifi cant. There were no signifi cant differences in the values of left ventricular ejection time index (LVETi), peak aortic blood fl ow acceleration (Acc) and total systemic vascular resistance index (TSVRi) between both study groups. Dynamic changes in LVETi, Acc and TSVRi are shown in Figure 4 . The time course of measured values of the CI describing the actual achievement of the target in both groups is shown in Figure 5 . More than 70 % of patients in both groups had the initial CI lower than 2.6 l/min/m 2 (median: 2.17 vs 2.19). However, the rate dropped to 10 % of patients after 20 minutes and always stayed lower than 5 % of patients during the further course of the procedure.
The dynamics of intraoperative catecholamine dosage also suggested that the initial higher doses of dobutamine and isosorbide dinitrate could be, after achieving the desired cardiac index, lowered and subsequently even discontinued. Despite the statistically signifi cant differences in the frequency of isosorbide dinitrate administration between the two groups, continuous administration of the infusion was terminated (after achievement of hemodynamic values according to protocol) in all patients before their surgery was completed. Besides, there were no signifi cant differences in the values of mean arterial pressure, central venous pressure and heart rate between both study groups, with all of them being within the normal interval (Fig. 5) .
With regard to postoperative complications, there was a statistical signifi cance related only to gastrointestinal tract dysfunction in the CRY group (31.6 %) vs the COL group (15.5 %; p = 0.05). The number of complications in hemodynamics, renal, respiratory and hematological parameters was not statistically signifi cant. The overall amount of complications during ICU stay was not significantly different. Also the length of ICU stay, the length of hospital stay and mortality were not signifi cantly different.
Discussion
The primary goal of fl uid therapy is reduction of plasma volume defi cit and thus to achieve an adequate CI, tissue perfusion and oxygen delivery. However, fl uid overload can cause excessive extravascular fl uid retention, pulmonary congestion and other complications (8, 9) . Vasoactive drugs may effectively prevent the complications. This rules have been derived from complex approach to Frank-Starling law (not only preload changes, but also afterload and contractility are responsible for curve shift) (10) . Therefore, optimal management might be a combination of fl uid and vasoactive therapy which maintains the CI index within the normal interval without excessive elevation of cardiac fi lling pressure or preventing the development of interstitial edema
The causes of perioperative hypovolemia are multifactorial, including preoperative fasting and bowel preparation (11, 12) . Hypovolemia induces peripheral vasoconstriction and microcirculatory compromise due to bar receptor refl ex-induced increase in sympathetic activity and release of catecholamine, and is an important factor contributing to organ failure.
After introduction to general anesthesia, worsening of global hemodynamic parameters is observed, especially preload, which causes reduction of the CI and parallel elevation of systemic vascular resistance (13) . However, traditional parameters such as heart rate (HR), mean arterial pressure (MAP) and central venous pressure (CVP) are often normal (14) . Use of anesthetics with cardiodepressive and vasodilator effects (15) or acute blood loss further enhance the negative impact on tissue perfusion.
There are no randomized controlled trials which would sufficiently evaluate interaction between the amounts of administered fl uids and vasoactive agents used to reduce hypoperfusion abnormalities in relation to outcome of patients undergoing elective major surgery, trauma, sepsis or burns (16) . Recommendation for volume resuscitation of early hypoperfusion abnormalities is based on identifi cation of real intravascular volume defi ciency and also on knowledge about different biological and physicochemical properties of crystalloid and colloid solutions such as the length of volume-expansion effect, hemorrheologic properties (with infl uence on vascular integrity and immunologic response) and simultaneously reduction of potential adverse effects of any administered fl uids (8, 17) .
Perioperative fl uids amount should be directed by reaching individual hemodynamic goals. Administration of crystalloids is suffi cient for reaching euvolemia in almost all clinical situations. Administration of colloids (both natural and synthetic) should always be justifi ed by real need of fast volume replacement and measurement of dynamic fl ow parameters.
From healthy volunteer studies and also from clinical practice, it is clear that for achievement of the same equivalent plasma volume expansion effect, 3-4 times the amount of crystalloids is needed as compared to colloids (18, 19) . In the SAFE study, during the fi rst 4 days of hospital stay at an intensive care unit, the crystalloid to 4% albumin ratio was found to range from 1.16 to 1.4 : 1. Similar results (crystalloid: colloid; 1:1.45) were noted in septic patients in the VISEP study where the goals of hemodynamic optimization were adjustments in HR, MAP, CVP and mixed venous oxygen saturation (5, 20) . Nevertheless, a recent study performed in an early postoperative period showed that while using the same amounts of different solutions, colloids are more effective in increasing cardiac fi lling, output and oxygen delivery than administration of Ringer's solution (21) . Interaction between amounts of administered fl uid and vasoactive agents was not evaluated.
The results of our study confi rmed the assumption that hypovolemia can be frequently found in patients undergoing major elective surgery (13, 22) . We also verifi ed high signifi cance of fl ow-related parameters for detection of hypoperfusion abnormalities (23, 24, 25) while using TED. The study proved that both crystalloids and colloids are effi cient tools correcting early fl ow hemodynamic abnormalities, but there was no statistically signifi cant difference in some important outcome parameters such as the overall frequency of postoperative complications, length of ICU stay, overall length of hospitalization and in-hospital mortality. On the other hand, statistically signifi cant differences in the amount of administered crystalloid and colloid solutions suggest different expansion characteristics. The extension of the therapeutic algorithm by the use of vasoactive drugs aids in avoiding potential adverse events resulting from fl uid overload (26, 27) . Effectiveness of therapeutic algorithm was proven in 230 surgical patients. Mortality, rate of perioperative complications, length of hospital stay were all lower in group with optimization of fl ow parameters compared to the group with standard perioperative monitoring only (28) . We also verifi ed their infl uence on correction of altered parameters of global perfusion, which fi nally helped us adjust the infused amounts of crystalloid and colloid solutions more effectively. Higher frequency of gastrointestinal tract complications in the group of patients using crystalloids reminds us of possible adverse effects resulting from administration of these solutions (29). Gut edema may be associated with postoperative gastrointestinal dysfunction, impairment of tissue oxygenation and increased intraabdominal pressure (7, (30) (31) (32) (33) . These results could be affected by different strategy of fl uid management in ICU, where no postoperative protocol was standardized.
We are aware of the limits of the study, namely the small number of patients and specifi city of major urologic surgery, which do not allow to exactly apply the results to another subpopulation of critically ill patients. Moreover, the used fl ow parameters to guide hemodynamic optimization could not suffi ciently defi ne preload, contractility and afterload. Nonetheless, we assume that these fl ow parameters are more accurate in titration of the amount of administered fl uid and vasoactive drugs in the intraoperative period and have better correlation to outcome, in comparison with the traditional parameters (HR, MAP and CVP) (34, 35) .
Conclusion
Despite considerable attention dedicated to perioperative medicine and signifi cant advances in technology of perioperative hemodynamic monitoring devices, there are no standardized procedures and protocols recommending the dosage of fl uids and vasoactive drugs. Early detection of intravascular volume defi ciency by fl ow-related parameters is an effective tool in amelioration of hypoperfusion abnormalities. In these situations, both crystalloid and colloid solutions may still be administered together with vasoactive drugs to avoid adverse effects generally related to fl uid therapy. To prove this in other groups of patients, more extensive randomized controlled trials are needed. Defi nition of hemodynamic parameters and creating algorithms allowing early and adequate therapeutic intervention therefore remain a great challenge for future perioperative research.
